Company News

Meet DIMA at 2024 PEGS and CSA Annual Meeting in May

DIMA extends a warm invitation to all attendees to visit our booth and explore how DIMA Biotech can elevate your research endeavors.

Special Promotion on Full-length Popular Drug Target Proteins!

Date: May 01,2024 -June 31,2024

a special price of $480 for a 50 μg size or $640 for a 100 μg size


Revolutionizing Drug Development: Synthetic Nanodiscs

December 6, 2023 Time: 7:00 AM CST

Unlock the Potential of ‘Undruggable’ Membrane Proteins

pages-Cancer 2023 1080x1080 1

Cancer Research & Immuno-Oncology Week Virtual Event Series 2023

Activity time: October 3 – 5, 2023

DIMA invites you to attend the Cancer Research & Immuno-Oncology Week Virtual Event Series, an online-only virtual event occurring on October 3 – 5, 2023.

DIMABIO Summer Price-small icon

Summer Promotion-Popular drug target proteins with 50% OFF

Activity time: 2023.07.01-2023.09.01

In order to appreciate customers’ attention on DIMABIO, we offer 50% OFF on selective Extracellular Domain (ECD) protein products.

PEGS Boston: The Essential Protein Engineering & Cell Therapy Summit 2023

Dates: May 15th -19th, 2023
Location: Boston, MA – Hynes Convention Center and virtual 

Using Single B Technology to Develop Lead Antibody Molecules on GPCR Targets with Live Q&A


We’re presenting at the Drug Discovery ……

Immuno-Oncology target|BCMA (1)


The racetrack is crowded……

Will SIRPα antibody combinatorial therapy be the next research hotspot?


SIRPα, a transmembrane protein expressed on macrophages and bone marrow cells, binds to its ligand CD47 to produce a “don’t eat me” signal that prevents macrophages from phagocytizing healthy cells.

Immune checkpoints proteins


Immune checkpoints are regulators that can inhibit or activate our immune system. They play essential roles in maintaining immune tolerance and modulating the duration and strength of immune responses.

New product release: SARS-CoV-2 functional proteins


To help our customers quickly evaluta the bioactivity of our SARS-CoV-2 S protein products, we include two small packages of CB6 and CR3022 monoclonal antibodies as free sample kit if you order the standard 100 ug or above package.

Events of 2020


Dima Biotech is attending or presents new products in the following international conferences:

First full length rabbit sourced mAb approved by FDA


FDA approved the listing of Eptinezumab, a CGRP antibody of Danish Lundbeck pharmaceutical, under the trade name of Vyepti, to prevent migraine On February 22, 2022. Since 1986, FDA has approved more than 90 new monoclonal antibody…